London, X0, based Investment company Abingworth LLP (Current Portfolio) buys Phathom Pharmaceuticals Inc, Soleno Therapeutics Inc, Protara Therapeutics Inc, sells Sierra Oncology Inc, Chiasma Inc during the 3-months ended 2020Q2, according to the most recent filings of the investment company, Abingworth LLP. As of 2020Q2, Abingworth LLP owns 13 stocks with a total value of $216 million. These are the details of the buys and sells.

For the details of Abingworth LLP's stock buys and sells,
go to www.gurufocus.com/guru/abingworth+llp/current-portfolio/portfolio

These are the top 5 holdings of Abingworth LLP

  1. Personalis Inc (PSNL) - 5,449,294 shares, 32.76% of the total portfolio.
  2. Phathom Pharmaceuticals Inc (PHAT) - 1,203,135 shares, 18.26% of the total portfolio. New Position
  3. CRISPR Therapeutics AG (CRSP) - 519,198 shares, 17.65% of the total portfolio.
  4. Soleno Therapeutics Inc (SLNO) - 10,302,602 shares, 10.56% of the total portfolio. Shares added by 47.83%
  5. Exicure Inc (XCUR) - 6,977,000 shares, 7.86% of the total portfolio.

New Purchase: Phathom Pharmaceuticals Inc (PHAT)

Abingworth LLP initiated holding in Phathom Pharmaceuticals Inc. The purchase prices were between $25.06 and $54.6, with an estimated average price of $38.17. The stock is now traded at around $40.19. The impact to a portfolio due to this purchase was 18.26%. The holding were 1,203,135 shares as of .

New Purchase: Protara Therapeutics Inc (TARA)

Abingworth LLP initiated holding in Protara Therapeutics Inc. The purchase prices were between $22 and $60.7, with an estimated average price of $30.86. The stock is now traded at around $24.52. The impact to a portfolio due to this purchase was 1.39%. The holding were 53,612 shares as of .

Added: Soleno Therapeutics Inc (SLNO)

Abingworth LLP added to a holding in Soleno Therapeutics Inc by 47.83%. The purchase prices were between $1.77 and $4.23, with an estimated average price of $2.9. The stock is now traded at around $1.99. The impact to a portfolio due to this purchase was 3.42%. The holding were 10,302,602 shares as of .

Sold Out: Sierra Oncology Inc (SRRA)

Abingworth LLP sold out a holding in Sierra Oncology Inc. The sale prices were between $8.88 and $15.31, with an estimated average price of $12.34.

Sold Out: Chiasma Inc (CHMA)

Abingworth LLP sold out a holding in Chiasma Inc. The sale prices were between $3.39 and $7.04, with an estimated average price of $5.47.

Here is the complete portfolio of Abingworth LLP. Also check out:

1. Abingworth LLP's Undervalued Stocks
2. Abingworth LLP's Top Growth Companies, and
3. Abingworth LLP's High Yield stocks
4. Stocks that Abingworth LLP keeps buying



Source link